$KROS Keros Therapeutics, Inc. Insider Trading Week 19/2021
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Keros Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in Keros Therapeutics, Inc. in week 19/2021.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Option Exercise | M | 0.48 | 1,000 | 480 | 99,211 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Option Exercise | M | 0.48 | 1,000 | 480 | 99,211 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Sell | S | 50.15 | 1,000 | 50,150 | 0 | 1,000 to 0 (-100.00 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Sell | S | 50.15 | 1,000 | 50,150 | 0 | 1,000 to 0 (-100.00 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Buy | M | 0.48 | 1,000 | 480 | 1,000 | 0 to 1,000 |
| May 13 2021 | KROS | Keros Therapeutics ... | Ordonez Claudia | Chief Medical Offic ... | Buy | M | 0.48 | 1,000 | 480 | 1,000 | 0 to 1,000 |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 500 | 150 | 7,793 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 500 | 150 | 7,793 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.11 | 6,220 | 684 | 0 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.11 | 6,220 | 684 | 0 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 2,650 | 795 | 132,355 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Option Exercise | M | 0.30 | 2,650 | 795 | 132,355 | |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 500 | 150 | 77,907 | 77.4 K to 77.9 K (+0.65 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 500 | 150 | 77,907 | 77.4 K to 77.9 K (+0.65 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.11 | 6,220 | 684 | 77,407 | 71.2 K to 77.4 K (+8.74 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.11 | 6,220 | 684 | 77,407 | 71.2 K to 77.4 K (+8.74 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 50.00 | 2,650 | 132,500 | 71,187 | 73.8 K to 71.2 K (-3.59 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Sell | S | 50.00 | 2,650 | 132,500 | 71,187 | 73.8 K to 71.2 K (-3.59 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 2,650 | 795 | 73,837 | 71.2 K to 73.8 K (+3.72 %) |
| May 13 2021 | KROS | Keros Therapeutics ... | Lachey Jennifer | Chief Scientific Of ... | Buy | M | 0.30 | 2,650 | 795 | 73,837 | 71.2 K to 73.8 K (+3.72 %) |